Codruta Chiuzan (Cody Chiuzan)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Venues

Columbia University

Medical University of South Carolina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Columbia University Jul 01 2014

United States

Assistant Professor of Biostatistics :: Biostatistics

Education History

Medical University of South Carolina Aug 15 2009 - Jun 15 2014

United States

PHD :: Public Health

Publications

Kara I Cicero, Xolisile Dlamini, Yvonne Mavengere, Jessica Justman, Harriet Nuwagaba-Biribonwoha, Sindisiwe Dlamini, Mxolisi Dlamini, Simphiwe Ngwenyama, Cebisile Ngcamphalala, Andrea Low, Neena M Philip, Wafaa M El-Sadr, Ruben Sahabo, Tesfay Abreha, Sintayehu Temesgen, Nokuthula Mahlalela, Codruta Chiuzan, Yuxuan Chen, Samuel S Pan, Suzanne Lentzsch, Alfred I Neugut
Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa. JNCI cancer spectrum 8 (4) (2024)
Codruta Chiuzan, Hakim-Moulay Dehbi
The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies. Clinical trials (London, England) 21 (3) (2024)
Safiya Richardson, Katherine L Dauber-Decker, Jeffrey Solomon, Pradeep Seelamneni, Sundas Khan, Douglas P Barnaby, John Chelico, Michael Qiu, Yan Liu, Shreya Sanghani, Stephanie M Izard, Codruta Chiuzan, Devin Mann, Renee Pekmezaris, Thomas McGinn, Michael A Diefenbach
Effect of a behavioral nudge on adoption of an electronic health record-agnostic pulmonary embolism risk prediction tool: a pilot cluster nonrandomized controlled trial. JAMIA open 7 (3) (2024)
Safiya Richardson, Katherine L Dauber-Decker, Jeffrey Solomon, Pradeep Seelamneni, Sundas Khan, Douglas P Barnaby, John Chelico, Michael Qiu, Yan Liu, Shreya Sanghani, Stephanie M Izard, Codruta Chiuzan, Devin Mann, Renee Pekmezaris, Thomas McGinn, Michael A Diefenbach
Effect of a behavioral nudge on adoption of an electronic health record-agnostic pulmonary embolism risk prediction tool: a pilot cluster nonrandomized controlled trial. JAMIA open 7 (3) (2024)
Codruta Chiuzan, Hakim-Moulay Dehbi
The 3 + 3 design in dose-finding studies with small sample sizes: Pitfalls and possible remedies. Clinical trials (London, England) (2024)
Kara I Cicero, Xolisile Dlamini, Yvonne Mavengere, Jessica Justman, Harriet Nuwagaba-Biribonwoha, Sindisiwe Dlamini, Mxolisi Dlamini, Simphiwe Ngwenyama, Cebisile Ngcamphalala, Andrea Low, Neena M Philip, Wafaa M El-Sadr, Ruben Sahabo, Tesfay Abreha, Sintayehu Temesgen, Nokuthula Mahlalela, Codruta Chiuzan, Yuxuan Chen, Samuel S Pan, Suzanne Lentzsch, Alfred I Neugut
Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa. JNCI cancer spectrum 8 (4) (2024)
Safiya Richardson, Katherine L Dauber-Decker, Jeffrey Solomon, Pradeep Seelamneni, Sundas Khan, Douglas P Barnaby, John Chelico, Michael Qiu, Yan Liu, Shreya Sanghani, Stephanie M Izard, Codruta Chiuzan, Devin Mann, Renee Pekmezaris, Thomas McGinn, Michael A Diefenbach
Effect of a behavioral nudge on adoption of an electronic health record-agnostic pulmonary embolism risk prediction tool: a pilot cluster nonrandomized controlled trial. JAMIA open 7 (3) (2024)
Kara I Cicero, Xolisile Dlamini, Yvonne Mavengere, Jessica Justman, Harriet Nuwagaba-Biribonwoha, Sindisiwe Dlamini, Mxolisi Dlamini, Simphiwe Ngwenyama, Cebisile Ngcamphalala, Andrea Low, Neena M Philip, Wafaa M El-Sadr, Ruben Sahabo, Tesfay Abreha, Sintayehu Temesgen, Nokuthula Mahlalela, Codruta Chiuzan, Yuxuan Chen, Samuel S Pan, Suzanne Lentzsch, Alfred I Neugut
Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa. JNCI cancer spectrum 8 (4) (2024)
Jonathan B Edmiston, Elizabeth G Cohn, Sergio L Teruya, Natalia Sabogal, Daniel Massillon, Varsha Muralidhar, Carlos Rodriguez, Stephen Helmke, Denise Fine, Morgan Winburn, Codruta Chiuzan, Eldad A Hod, Farbod Raiszadeh, Damien Kurian, Mathew S Maurer, Frederick L Ruberg
Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study. PloS one 18 (3) (2023)
Frederick L Ruberg, William S Blaner, Codruta Chiuzan, Lawreen H Connors, Andrew J Einstein, Denise Fine, Stephen Helmke, Damian Kurian, Shivda Pandey, Farbod Raiszadeh, Carlos Rodriguez, Natalia Sabogal, Sergio Teruya, Morgan Winburn, Wendy K Chung, Elizabeth Cohn, Robert J H Miller, Jeffrey W Kelly, Mathew S Maurer
Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association (2023)
Jonathan B Edmiston, Elizabeth G Cohn, Sergio L Teruya, Natalia Sabogal, Daniel Massillon, Varsha Muralidhar, Carlos Rodriguez, Stephen Helmke, Denise Fine, Morgan Winburn, Codruta Chiuzan, Eldad A Hod, Farbod Raiszadeh, Damien Kurian, Mathew S Maurer, Frederick L Ruberg
Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study. PloS one 18 (3) (2023)
Jonathan B Edmiston, Elizabeth G Cohn, Sergio L Teruya, Natalia Sabogal, Daniel Massillon, Varsha Muralidhar, Carlos Rodriguez, Stephen Helmke, Denise Fine, Morgan Winburn, Codruta Chiuzan, Eldad A Hod, Farbod Raiszadeh, Damien Kurian, Mathew S Maurer, Frederick L Ruberg
Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study. PloS one 18 (3) (2023)
Jonathan B Overdevest, Alexandria Lauren Irace, Valeria Mazzanti, Eun Jeong Oh, Paule Valery Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan
Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. PloS one 17 (12) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer 4 (2) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer 4 (2) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer (2022)
Jonathan B Overdevest, Alexandria Lauren Irace, Valeria Mazzanti, Eun Jeong Oh, Paule Valery Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan
Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. PloS one 17 (12) (2022)
Kara I Cicero, Maureen Joffe, Moosa Patel, Codruta Chiuzan, Audrey Pentz, Paul Ruff, Suzanne Lentzch, Siyang Leng, Judith S Jacobson, Timothy R Rebbeck, Alfred I Neugut
Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (12) (2022)
Jonathan B Overdevest, Alexandria Lauren Irace, Valeria Mazzanti, Eun Jeong Oh, Paule Valery Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan
Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. PloS one 17 (12) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer 4 (2) (2022)
Robyn D Gartrell, Zoë Blake, Emanuelle M Rizk, Rolando Perez-Lorenzo, Stuart P Weisberg, Ines Simoes, Camden Esancy, Yichun Fu, Danielle R Davari, Luke Barker, Grace Finkel, Manas Mondal, Hanna E Minns, Samuel W Wang, Benjamin T Fullerton, Francisco Lozano, Codruta Chiuzan, Basil Horst, Yvonne M Saenger
Combination immunotherapy including OncoVEX mGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma. Cancer immunology, immunotherapy : CII 71 (8) (2022)
Jonathan B Overdevest, Alexandria Lauren Irace, Valeria Mazzanti, Eun Jeong Oh, Paule Valery Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan
Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. PloS one 17 (12) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer 4 (2) (2022)
Robyn D Gartrell, Thomas Enzler, Pan S Kim, Benjamin T Fullerton, Ladan Fazlollahi, Andrew X Chen, Hanna E Minns, Subha Perni, Stuart P Weisberg, Emanuelle M Rizk, Samuel Wang, Eun Jeong Oh, Xinzheng V Guo, Codruta Chiuzan, Gulam A Manji, Susan E Bates, John Chabot, Beth Schrope, Michael Kluger, Jean Emond, Raul Rabadán, Donna Farber, Helen E Remotti, David P Horowitz, Yvonne M Saenger
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. Oncoimmunology 11 (1) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer (2022)
Jonathan B Overdevest, Alexandria Lauren Irace, Valeria Mazzanti, Eun Jeong Oh, Paule Valery Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan
Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. PloS one 17 (12) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer 4 (2) (2022)
Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J Alvarez, Erin Honan, Min Yang, Pei Ling Chia, Partha Mukhopadhyay, Sean Kelly, Ruby Wu, Kathleen Fenn, Meghna S Trivedi, Melissa K Accordino, Katherine D Crew, Dawn L Hershman, Matthew Maurer, Simon Jones, Anthony High, Junmin Peng, Andrea Califano, Kevin M Kalinsky, Jiyang Yu, Jose Silva
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer 4 (2) (2022)
Jonathan B Overdevest, Alexandria Lauren Irace, Valeria Mazzanti, Eun Jeong Oh, Paule Valery Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan
Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. PloS one 17 (12) (2022)
Hiroshi Mitsumoto, Codruta Chiuzan, Madison Gilmore, Yuan Zhang, Camila Ibagon, Brittany McHale, Jonathan Hupf, Björn E Oskarsson
A novel muscle cramp scale (MCS) in amyotrophic lateral sclerosis (ALS). Amyotrophic lateral sclerosis & frontotemporal degeneration 20 (5-6) (2019)

Codruta Chiuzan.css-eqlu8i{font-size:small;padding-left:4px;} (Cody Chiuzan)

Publication Activity (10 Years)

Top Topics

Top Venues

Codruta Chiuzan (Cody Chiuzan)